{"uid":"AMANR5L17PO420120B2141P0D1N000155","chronotag":"1764424112906","legislature":"17","identification":{"numeroLong":"AS155","numeroOrdreDepot":"155","prefixeOrganeExamen":"CION-SOC","numeroRect":"0"},"examenRef":"EXANR5L17PO420120B2141P0D1","texteLegislatifRef":"PRJLANR5L17B2141","triAmendement":"cacaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaatc","cardinaliteAmdtMultiples":"1","amendementParentRef":{},"signataires":{"auteur":{"typeAuteur":"D\u00e9put\u00e9","gouvernementRef":{},"acteurRef":"PA794138","groupePolitiqueRef":"PO845413","auteurRapporteurOrganeRef":{}},"cosignataires":{"acteurRef":["PA795228","PA793262","PA794906","PA795588","PA795084","PA842105","PA841657","PA720430","PA793772","PA795616","PA793444","PA794938","PA795318","PA841023","PA796090","PA793912","PA842187","PA842037","PA791812","PA793736","PA721202","PA795136","PA793464","PA842155","PA795200","PA795844","PA841251","PA794786","PA794870","PA796070","PA795310","PA794478","PA841947","PA794082","PA794130","PA720846","PA841729","PA795516","PA841515","PA795672","PA795108","PA795298","PA791824","PA842029","PA793532","PA795746","PA342384","PA795422","PA794686","PA841215","PA795482","PA610654","PA841191","PA721960","PA793872","PA720892","PA817211","PA793756","PA796062","PA719578","PA721062","PA841845","PA795982","PA795466","PA793744","PA720952","PA794106","PA794166","PA795164","PA795596"]},"suffixe":{},"libelle":" Mme\u0026#160;Amiot,  Mme\u0026#160;Abomangoli, M.\u0026#160;Alexandre, M.\u0026#160;Amard, Mme\u0026#160;Amrani, M.\u0026#160;Arenas, M.\u0026#160;Arnault, Mme\u0026#160;Belouassa-Cherifi, M.\u0026#160;Bernalicis, M.\u0026#160;Bex, M.\u0026#160;Bilongo, M.\u0026#160;Bompard, M.\u0026#160;Boumertit, M.\u0026#160;Boyard, M.\u0026#160;Cadalen, M.\u0026#160;Caron, M.\u0026#160;Carri\u0026#232;re, Mme\u0026#160;Cathala, M.\u0026#160;Cernon, Mme\u0026#160;Chikirou, M.\u0026#160;Clouet, M.\u0026#160;Coquerel, M.\u0026#160;Coulomme, M.\u0026#160;Delogu, M.\u0026#160;Diouara, Mme\u0026#160;Dufour, Mme\u0026#160;Erodi, Mme\u0026#160;Feld, M.\u0026#160;Fernandes, Mme\u0026#160;Ferrer, M.\u0026#160;Gaillard, Mme\u0026#160;Guett\u0026#233;, M.\u0026#160;Guiraud, Mme\u0026#160;Hamdane, Mme\u0026#160;Hignet, M.\u0026#160;Kerbrat, M.\u0026#160;Lachaud, M.\u0026#160;Lahmar, M.\u0026#160;Laisney, M.\u0026#160;Le\u0026#160;Coq, M.\u0026#160;Le\u0026#160;Gall, Mme\u0026#160;Leboucher, M.\u0026#160;Legavre, Mme\u0026#160;Legrain, Mme\u0026#160;Lejeune, Mme\u0026#160;Lepvraud, M.\u0026#160;L\u0026#233;aument, Mme\u0026#160;\u0026#201;lisa\u0026#160;Martin, M.\u0026#160;Maudet, Mme\u0026#160;Maximi, Mme\u0026#160;Mesmeur, Mme\u0026#160;Manon\u0026#160;Meunier, M.\u0026#160;Nilor, Mme\u0026#160;Nosb\u0026#233;, Mme\u0026#160;Obono, Mme\u0026#160;Oziol, Mme\u0026#160;Panot, M.\u0026#160;Pilato, M.\u0026#160;Piquemal, M.\u0026#160;Portes, M.\u0026#160;Prud\u0026apos;homme, M.\u0026#160;Ratenon, M.\u0026#160;Saint-Martin, M.\u0026#160;Saintoul, Mme\u0026#160;Soudais, Mme\u0026#160;Stambach-Terrenoir, M.\u0026#160;Aur\u0026#233;lien\u0026#160;Tach\u0026#233;, Mme\u0026#160;Taurinya, M.\u0026#160;Tavel, Mme\u0026#160;Trouv\u0026#233; et M.\u0026#160;Vannier"},"pointeurFragmentTexte":{"partieAmendableRef":{},"division":{"titre":"Article 10","articleDesignationCourte":"ART. 10","articleDesignation":"ARTICLE 10","type":"ARTICLE","avant_A_Apres":"A","divisionRattachee":{},"articleAdditionnel":"false","chapitreAdditionnel":"false","urlDivisionTexteVise":"\/17\/textes\/2141.asp#D_Article_10"},"amendementStandard":{"alinea":{"avant_A_Apres":{},"numero":"22","alineaDesignation":"Alin\u00e9a 22"}}},"corps":{"cartoucheInformatif":{},"contenuAuteur":{"dispositif":"\u003Cp style=\u0022text-align: justify;\u0022\u003E\u0026#x00C0;\u0026nbsp;la fin de l\u0026#x2019;alin\u0026#x00E9;a\u0026nbsp;22, substituer au taux\u0026nbsp;:\u003C\/p\u003E\u003Cp style=\u0022text-align: justify;\u0022\u003E\u0026#x00AB;\u0026nbsp;1,6\u0026nbsp;%\u0026nbsp;\u0026#x00BB;\u0026nbsp;\u003C\/p\u003E\u003Cp style=\u0022text-align: justify;\u0022\u003Ele taux\u0026nbsp;:\u003C\/p\u003E\u003Cp style=\u0022text-align: justify;\u0022\u003E\u0026#x00AB;\u0026nbsp;3,2\u0026nbsp;%\u0026nbsp;\u0026#x00BB;.\u003C\/p\u003E","avantAppel":{},"exposeSommaire":"\u003Cp style=\u0022text-align: justify;\u0022\u003EPar cet amendement, le groupe parlementaire La France insoumise propose une hausse de la contribution de base des laboratoires pharmaceutiques.\u003C\/p\u003E\u003Cp style=\u0022text-align: justify;\u0022\u003ELa progression des d\u0026#x00E9;penses de m\u0026#x00E9;dicaments est principalement du fait des strat\u0026#x00E9;gies commerciales des laboratoires pharmaceutiques. Leurs prix, \u0026#x00E9;tablis en toute opacit\u0026#x00E9;, sont d\u0026#x00E9;connect\u0026#x00E9;s du co\u0026#x00FB;t r\u0026#x00E9;el de recherche et d\u0026#x00E9;veloppement et du co\u0026#x00FB;t de production des produits.\u003C\/p\u003E\u003Cp style=\u0022text-align: justify;\u0022\u003ECe sont donc des ressources de l\u0026#x2019;Assurance maladie qui vont \u0026#x00E0; la r\u0026#x00E9;mun\u0026#x00E9;ration de ces laboratoires alors qu\u0026#x2019;elles pourraient \u0026#x00EA;tre mobilis\u0026#x00E9;es afin de r\u0026#x00E9;pondre aux besoins de sant\u0026#x00E9; non couverts.\u003C\/p\u003E\u003Cp style=\u0022text-align: justify;\u0022\u003ELes laboratoires b\u0026#x00E9;n\u0026#x00E9;ficient d\u0026#x2019;un r\u0026#x00E9;gime socio-fiscal avantageux.\u003C\/p\u003E\u003Cp style=\u0022text-align: justify;\u0022\u003ELe taux de la contribution additionnelle sur le chiffre d\u0026#x2019;affaires de leurs m\u0026#x00E9;dicaments remboursables est aujourd\u0026#x2019;hui fix\u0026#x00E9; \u0026#x00E0; 1,6\u0026nbsp;%. Nous proposons de le doubler.\u003C\/p\u003E\u003Cp style=\u0022text-align: justify;\u0022\u003ECette mesure permettra de d\u0026#x00E9;gager des recettes nouvelles, alors que leur contribution totale est aujourd\u0026#x2019;hui limit\u0026#x00E9;e, notamment par le plafonnement \u0026#x00E0; 1,6 milliard d\u0026#x2019;euros que le Gouvernement conserve malgr\u0026#x00E9; le transfert de rendement de la clause de sauvegarde vers une contribution suppl\u0026#x00E9;mentaire.\u003C\/p\u003E","annexeExposeSommaire":{}}},"cycleDeVie":{"dateDepot":"2025-11-27","datePublication":"2025-11-28","soumisArticle40":"false","etatDesTraitements":{"etat":{"code":"DI","libelle":"Discut\u00e9"},"sousEtat":{"code":"DI","libelle":"Rejet\u00e9"}},"dateSort":"2025-11-29T14:48:10+01:00","sort":"Rejet\u00e9"},"representations":{"representation":{"nom":"PDF","typeMime":{"type":"application","subType":"PDF"},"statutRepresentation":{"verbatim":"true","canonique":"true","officielle":"true","transcription":"false","enregistrement":"false"},"repSource":{},"offset":{},"contenu":{"documentURI":"\/base\/AMANR5L17PO420120B2141P0D1N000155?format=pdf"},"dateDispoRepresentation":{}}},"seanceDiscussionRef":{},"article99":"false","loiReference":{},"discussionCommune":{"idDiscussion":"35091","typePosition":"Premier"},"discussionIdentique":{},"accordGouvernementDepotHorsDelai":"Sans objet"}